Radioactive beads show promise for liver tumors in french registry
NCT ID NCT03256994
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed registry tracked 332 liver cancer patients in France who received SIR-Spheres, tiny radioactive beads injected into the liver's blood supply to target tumors. The goal was to see how this treatment is used in everyday practice and to monitor safety and survival. Results will help guide future use and reimbursement decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Yttrium-90 loaded SIR-Spheres microspheres (radioactive beads delivered via catheter to liver tumors)
What this could lead to
If results are positive, this could confirm that SIR-Spheres are a safe and effective option for controlling liver tumors in real-world practice.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by patient selection and other treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU de Strasbourg
Strasbourg, France
-
CHU d'Angers
Angers, France
-
CHU de Bordeaux
Bordeaux, France
-
CHU de Grenoble Alpes
Grenoble, France
-
CHU de Lyon
Lyon, France
-
CHU de Nimes
Nîmes, France
-
CHU de Poitiers
Poitiers, France
-
Centre Léon Bérard
Lyon, France
-
Chu de Dijon
Dijon, France
-
Hôpital Beaujon
Clichy, France
-
Hôpital Henri Mondor
Créteil, France
-
Institut Gustave Roussy
Paris, France
-
Institut Paoli-Calmettes
Marseille, France